Clinical Evaluation of Viral Hepatitis and Gastrointestinal Cancer Risk
Cover Page
Clinical Evaluation of Viral Hepatitis and Gastrointestinal Cancer Risk
Student Name
Institutional Affiliation
Instructor's Name
Course
Date
Clinical Assessment of Hepatitis A and Hepatitis B
Question #1: Probable Viral Hepatitis Diagnoses and Associated Risk Factors
The patient might have acquired hepatitis A and hepatitis B based on his lifestyle. An individual with hepatitis A typically complains of stomach aches and flu-like clinical manifestations. The use of infected needles, direct interaction with an infected individual, and sexual relations with an infected individual are the three main ways that hepatitis A is typically spread (Dlugasch & Story, 2019). As such, the patient's habits and the manifestations described in the scenario are comparable to the signs and symptoms of hepatitis A. Increased liver enzyme levels are another indication of hepatitis A. Conversely, an individual with hepatitis B also exhibits flu-like signs during the initial stages, along with abdominal discomfort (Razavi, 2020). Sexual relations, the use of contaminated needles, and any other activity that involves the transmission of bodily fluids are the main ways in which hepatitis B is spread (Dlugasch & Story, 2019). In patients with hepatitis B, liver enzyme levels are also elevated. The patient is therefore likely to have contracted both types of viruses based on the clinical manifestations and other information presented in the case, and specialized diagnostic tests can be performed to identify the viral type. Unprotected sexual contact and the use of illegal substances are risk factors for hepatitis A and B. Illegal drug use is one of the risk factors for hepatitis B.
Question #2: Diagnostic Confirmation of Viral Hepatitis
Blood tests that detect the specific antibodies associated with viral hepatitis can be used to confirm a differential diagnosis of hepatitis. They demonstrate that hepatitis is caused by a specific viral infection. It is also possible to perform an ultrasound of the liver, which would support the identification of hepatitis by showing that the liver is affected (Seladi-Schulman, 2021). In addition, a differential diagnosis of hepatitis can be confirmed by the detection of viral particles in the stool. According to previous research, hepatitis A is caused by the hepatitis A virus (HAV). Individuals become infected with HAV when the virus is present in feces. Even when an object appears clean, placing something in the mouth that has been contaminated with the feces of a patient with hepatitis A can easily spread the infection from one person to another.
Question #3: Interpretation of Hepatitis B Serological Test Results
The findings mentioned above are consistent with an acute hepatitis B infection. However, every test evaluates a different effect. The presence of anti-HBs indicates that the subject is resistant to or protected from the hepatitis B virus (HBV). The presence of anti-HBc (IgM), which implies that fewer than six months have passed since infection, indicates a current hepatitis B virus infection. If the HBsAg test is positive, the individual has hepatitis B. Ultimately, if HBsAg is negative, it could suggest that the individual does not have a hepatitis infection (Dlugasch & Story, 2019). The detection of antibodies produced in response to HBV infection is another benefit of anti-HBs testing. Positive results imply that the subject was exposed to the virus and developed resistance to it. Immunoglobulin M (IgM) antibodies produced in response to a hepatitis B virus infection are detected by the anti-HBc (IgM) test, indicating an acute stage of infection. A positive test means that the person has recently been infected with the illness. Hepatitis B surface antigen is detected in the blood during an infection by the HBsAg test (Abdou et al., 2020). A positive result indicates that the subject has been exposed to the virus. The HBsAg test may return a negative result in a case of acute hepatitis B. This is because the amount of HBsAg present during the early phases of infection may not be detectable.
Question #4: Sexual and Drug-Related Transmission of Hepatitis Viruses
They most likely infected each other through sexual activity, drug use during previous relationships, or encounters involving shared drugs or injection equipment (Dlugasch & Story, 2019). Transmission of the hepatitis A virus is possible during any sexual encounter with an infected person and is not limited to contact with feces. Hepatitis A infection is a risk for sexual partners who use injectable drugs, are men who have sex with men (MSM), reside with an infected person, or have sexual contact with an infected person. Hepatitis A virus transmission is not limited to fecal-oral contact and can result from any type of sexual encounter with an infected individual. If a person injects drugs, is MSM, lives with an infected person, or has sex with an infected person, the individual is at risk of contracting hepatitis A. Sexual activity can spread the hepatitis B virus. There is a higher risk of transmission among unvaccinated individuals who have multiple sexual partners and among partners of individuals with chronic hepatitis B infection. Other frequent methods of hepatitis B transmission in the United States include injection drug use and sexual contact. As many as 10% to 40% of individuals seeking medical treatment for sexually transmitted diseases have evidence of past or present hepatitis B virus infection. Through widespread immunization during the provision of STD control or therapeutic services, many of these infections could have been prevented.
Assessment of Gastrointestinal Cancer Risks Across Patient Profiles
Risk of Colorectal Cancer Associated with Chronic Bowel Changes
A 60-year-old woman has type 2 diabetes mellitus, a history of prolonged diarrhea, consumes one or two alcoholic beverages on alternate days, and has a history of constipation. In my opinion, she would probably develop colorectal cancer. The woman's chronic constipation places her at risk of colon cancer. Moreover, ongoing exposure to waste compromises the integrity of the intestinal wall. As a result, her alcohol consumption also increases the risk.
Risk of Esophageal Adenocarcinoma Associated with GERD and Barrett Esophagus
A 50-year-old woman recently underwent an upper endoscopy that revealed indications of Barrett esophagus in addition to long-standing GERD. Given her GERD and Barrett esophagus, which is the most common potential risk factor for this form of cancer, I think she will probably develop esophageal adenocarcinoma.
Risk of Pancreatic Adenocarcinoma Associated with Alcoholism and Pancreatitis
An obese 60-year-old woman has a history of alcoholism and pancreatitis. In my opinion, she would probably develop pancreatic cancer. Her risk of developing pancreatic adenocarcinoma is increased by her history of alcohol abuse and chronic pancreatic inflammation.
References on Viral Hepatitis and Associated Clinical Assessment
Abdou, A., Hasssan, M., El Gamal, S., & El Dewi, D. (2020). The role of detection of anti-HBc IgM in HBs Ag negative blood donors. Journal of Recent Advances in Medicine, 1(2), 67-74.
CDC. (2020, September 21). Sexual transmission and viral hepatitis. Centers for Disease Control and Prevention. Retrieved from https://www.cdc.gov/hepatitis/populations/stds.htm
Dlugasch, L., & Story, L. (2019). Applied pathophysiology for the advanced practice nurse. Jones & Bartlett Learning.
Razavi, H. (2020). Global epidemiology of viral hepatitis. Gastroenterology Clinics, 49(2), 179-189.
Seladi-Schulman, J. (2021, January 5). How do you get hepatitis B? causes, diagnosis, more. Healthline. Retrieved from https://www.healthline.com/health/how-do-you-get-hepatitis-b#risk-factors